Clinicopathologic and molecular characteristics of acral melanomas harboring RARA fusions

Human Pathology · Published 2026-07-03 · DOI 10.1016/j.humpath.2026.106211

Authors (5)

Mokhtar H. Abdelhammed, Richard K. Yang, Volha Lenskaya, Carlos A. Torres-Cabala, Woo Cheal Cho

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Abdelhammed, M., Yang, R., Lenskaya, V., et al. (2026). Clinicopathologic and molecular characteristics of acral melanomas harboring RARA fusions. Human Pathology. https://doi.org/10.1016/j.humpath.2026.106211

Related articles

• Association of genomic driver mutation, histologic subtype, and mTORC1 biomarker expression in mTOR pathway-altered renal tumors · Human Pathology · 2026 · Same journal
• Single-section assessment of DNA mismatch repair using PMS2/MSH6 double immunohistochemistry · Human Pathology · 2026 · Same journal
• Metastatic pancreatic acinar cell carcinoma to the liver mimicking neuroendocrine tumor (NET) and pancreatic ductal adenocarcinoma (PDAC): A series of seven cases · Human Pathology · 2026 · Same journal
• Morphology spectrum and molecular landscape in eosinophilic solid and cystic renal cell carcinoma · Human Pathology · 2026 · Same journal
• Histologic spectrum of BRCA-associated pancreatic ductal adenocarcinoma: A descriptive morphologic study · Human Pathology · 2026 · Same journal
• GPNMB immunohistochemistry distinguishes diagnostically challenging cases of lymphangioleiomyomatosis from other mesenchymal neoplasms presenting with cystic lung metastases · Human Pathology · 2026 · Same journal
• TSC gene-associated lesions of the lung · Human Pathology · 2026 · Same journal
• Mixed phenotype acute leukemia: Lineage assignment, immunophenotypic classification and genetic insights · Human Pathology · 2026 · Same journal
• Molecular Subtypes and Genetic Diagnostics in B-cell Acute Lymphoblastic Leukemia · Human Pathology · 2026 · Same journal
• TRPS1 and GATA3 expression in BRG1/SMARCA4-deficient malignant neoplasms · Human Pathology · 2026 · Same journal